Achieving optimal financial and strategic transaction outcomes for small to mid-sized privately funded start-ups
Non-dilutive funding and equity capital are two key reasons why life sciences companies pursue strategic partnerships. In fact alliances are also strong contributors to successful “exits”, whether Mergers and Acquisitions (M&A) (~ 40% of partn…